Tag - RCUS

Markets

BTIG ups Arcus Biosciences PT to $34 from $20

BTIG raised its price target for Arcus Biosciences (NYSE:RCUS) to $34 from $20, citing investors meetings with Arcus management that “reinforced careful development of important assets.” The stock closed at $15.58 on...

April 16, 2020

Executive Moves

Arcus Biosciences names Eric Hoefer as chief commercial officer

Arcus Biosciences (NYSE:RCUS) appointed Eric Hoefer as its chief commercial officer to oversee the company’s global commercial strategy and operations.

June 24, 2019

Tag - RCUS

BTIG ups Arcus Biosciences PT to $34 from $20

Arcus Biosciences names Eric Hoefer as chief commercial officer

General

More